| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 6,991 | 7,072 | 6,669 | 7,406 | | Cost of Revenue | 1,492 | 1,576 | 1,578 | 1,479 | | | Gross Profit | 5,499 | 5,496 | 5,091 | 5,927 | | | Operating Expenses | | Research Development | 1,290 | 1,445 | 1,045 | 1,209 | | Selling General and Administrative | 2,789 | 2,992 | 3,030 | 6,378 | | Non Recurring |
-
| 1,408 | 13,940 |
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 1,420 | (349) | (12,924) | (1,660) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| (2) | 2 | 19 | | Earnings Before Interest And Taxes | 1,060 | (351) | (12,922) | (1,641) | | Interest Expense | (233) | 112 | 121 | 367 | | Income Before Tax | 1,293 | (463) | (13,043) | (2,008) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 1,293 | (463) | (13,043) | (2,008) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 1,293 | (463) | (13,043) | (2,008) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $1,293 | ($463) | ($13,043) | ($2,008) |
|
0.31% Nasdaq 
0.05%
Income Statement
